Adam Schilt

Adam Schilt

Foley Hoag LLP

Contact
View Bio
RSS

Latest Posts › Biosimilars

Share:

Medicare Drug Price Negotiation Program Initial Guidance

On March 15, 2023, the Centers for Medicare & Medicaid Services (CMS) issued an initial guidance regarding the Medicare Drug Price Negotiation Program (Negotiation Program) established by the Inflation Reduction Act of 2022...more

3/31/2023  /  Biosimilars , Centers for Medicare & Medicaid Services (CMS) , Compliance , Drug Pricing , Food and Drug Administration (FDA) , Inflation Reduction Act (IRA) , Medicare , Negotiations , New Guidance , Section 340B
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide